Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

72 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQ
Dpa-AFX Overview: COMPANIES from 14.03.2024 - 15:15
DP
Dermapharm looks cautiously into the future - missing Covid business
DP
Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQ
Dermapharm Holding SE builds on success in Q3 2023
EQ
Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQ
Dermapharm becomes more optimistic after first half-year - share price jumps
DP
Dermapharm becomes more optimistic after first half year
DP
Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQ
DD: Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
EQ
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQ
Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQ
Dpa-AFX Overview: COMPANY as of 05/15/2023 - 3:15 p.m.
DP
Latest acquisition drives Dermapharm - share price rises sharply
DP
Latest acquisition drives drugmaker Dermapharm forward
DP
Dermapharm Holding SE: outstanding start to financial year 2023
EQ
Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQ
Dermapharm misses targets - decline in earnings expected in 2023
DP
Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQ
Dermapharm Holding SE successfully maintains growth trend as planned
EQ
DD: Dermapharm Holding SE : Notification and public disclosure of transactions by persons
EQ
Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
EQ
Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
EQ
Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
EQ
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
EQ
Dermapharm Holding SE: excellent start into financial year 2022
EQ
Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
EQ
Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022
EQ
Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook
EQ
Dermapharm Holding SE raises EBITDA forecast for the full year 2021
EQ
Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
EQ
Dermapharm Holding SE: strong EBITDA growth in Q3 2021
EQ
Dermapharm : publishes H1 2021 report, confirms outlook for 2021 overall
EQ
Dermapharm Holding SE: Adjusted EBITDA up almost 50% in H1 2021
EQ
Dermapharm : Bionity- Drug manufacturer Dermapharm invests millions in CORAT Therapeutics
AQ
Dermapharm : acquires equity investment in CORAT Therapeutics GmbH
EQ
Dermapharm Holding SE: Annual General Meeting approves dividend distribution of EUR 0.88 per share
EQ
Dermapharm Holding SE: accelerated EBITDA growth in Q1 2021
EQ
Dermapharm Holding SE: Federal Minister of Health Jens Spahn joins opening ceremony for vaccine manufacturing facility at subsidiary Allergopharma GmbH & Co. KG
EQ
Dermapharm : forecasts exceptionally strong growth for 2021 and confirms preliminary figures
EQ
Dermapharm : posts growth despite COVID-19 pandemic - consolidated revenue and EBITDA continue to rise
EQ
Dermapharm : aims to start making Pfizer shot at second site by May
RE
Dermapharm : continues on its growth course in third quarter of 2020
EQ
Dermapharm : subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main
EQ
Dermapharm Holding SE Begins Construction of Production, Storage and Administration Building At the Friedrichsdorf Site of Its Subsidiary Axicorp Gmbh
CI
Dermapharm : signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine
EQ
Dermapharm : publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic
EQ
Dermapharm : remains on growth course despite corona pandemic in the first half of 2020
EQ
Dermapharm Holding SE: Annual General Meeting approves dividend payout of EUR 0.80 per share
EQ
Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic
EQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Hans-Georg Feldmeier
  4. News